You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Colorcon
Harvard Business School
Medtronic
Merck

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC ALLERGY Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Children's Zyrtec Allergy, and what generic alternatives are available?

Children's Zyrtec Allergy is a drug marketed by J And J Consumer Inc and is included in two NDAs.

The generic ingredient in CHILDREN'S ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and forty suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Zyrtec Allergy

A generic version of CHILDREN'S ZYRTEC ALLERGY was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.

  Start Trial

Drug patent expirations by year for CHILDREN'S ZYRTEC ALLERGY
Recent Clinical Trials for CHILDREN'S ZYRTEC ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 4
Merck Sharp & Dohme Corp.Phase 3
PfizerPhase 4

See all CHILDREN'S ZYRTEC ALLERGY clinical trials

Synonyms for CHILDREN'S ZYRTEC ALLERGY
(+-)-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride
(+) {2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazine-1-yl] -ethoxy}-acetic acid dihydrochloride
(+/-)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]acetic acid, dihydrochloride
(+/-){2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid dihydrochloride
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride
(2-{4-[(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid--hydrogen chloride (1/2)
(R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy }-acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy}-acetic acid dihydrochloride
[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]aceticaciddihydrochloride
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
83881-52-1
881C510
A840675
AB0008484
AB1009381
AC-1600
AC-170
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-
AK108356
AK176131
AKOS000280979
AKOS016340521
Alercet
Alergex
Alerid
Alerlisin
Alertisin
Allergy relief
Alleroff
ANW-69482
API0001938
Apo-Cetirizine
AX8022801
BCP09018
BG0436
C21H25ClN2O3.2HCl
C21H27Cl3N2O3
CAS-83881-52-1
CC0256
CCG-213404
Cetalerg
Ceterifug
Ceti TAD
Ceti-Puren
Cetiderm
Cetidura
Cetil von ct
CetiLich
Cetirigamma
Cetirizin AZU
Cetirizin Basics
Cetirizin dihydrochloride, >=98.0% (HPLC)
Cetirizine (dihydrochloride)
Cetirizine 2HCl
Cetirizine Di
Cetirizine diHCl
Cetirizine dihydrochloride
Cetirizine Dihydrochloride 1.0 mg/ml in Water (as free base)
Cetirizine dihydrochloride solution, 1.0 mg/mL in acetonitrile: water (9:1) (as free base), ampule of 1 mL, certified reference material
Cetirizine dihydrochloride, >=98% (HPLC)
Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard
Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard
Cetirizine HCl
CETIRIZINE HYDROCHLORIDE
Cetirizine hydrochloride (JP17/USAN)
Cetirizine hydrochloride [USAN:USP]
Cetirizine hydrochloride [USAN]
Cetirizine Hydrochloride Allergy
Cetirizine Hydrochloride Hives
Cetirizine hydrochloride, British Pharmacopoeia (BP) Reference Standard
Cetirizine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
cetirizine-dihydrochloride
cetirizinedihydrochloride
Cetirlan
Cetriler
Cetrine
Cetzine
Cezin
CHEBI:3562
CHEMBL1607273
Children's Cetirizine hydrochloride allergy
Children's Cetirizine hydrochloride hives relief
Children's Zyrtec
Children's Zyrtec Hives Relief
CS-1798
CTK8C2999
D00664
DB-056756
DSSTox_CID_24268
DSSTox_GSID_44268
DSSTox_RID_80138
DTXSID2044268
Formistin
FT-0603000
HMS1569F07
HMS1922H04
HY-17042A
J10151
KS-000015AD
KS-1042
LP00362
LS-11411
NCGC00016949-01
NCGC00095180-01
NCGC00095180-02
NCGC00255965-01
NCGC00261047-01
NCGC00263567-01
OX-NLA
P 071
P-071
PGLIUCLTXOYQMV-UHFFFAOYSA-N
Prestwick_841
Q27263769
Reactine
Ressital
Riztec
RTR-026026
Ryzen
s1291
Salvalerg
SCHEMBL41107
Setiral
SPECTRUM1505371
SR-01000688282
SR-01000688282-3
ST077146
ST24039138
Stopaler
Sun mark all day allergy
SW196972-3
Topcare all day allergy
Tox21_110704
Tox21_110704_1
Tox21_302261
Tox21_500362
Triz
UCB P071
UCB-P 071
Up and up all day allergy relief
Virdos
Voltric
Xero-sed
Zerviate
Zetir
Zirtin
Zyrtec
Zyrtec (TN)
Zyrtec Allergy
Zyrtec Hives Relief
Zyrzine
Paragraph IV (Patent) Challenges for CHILDREN'S ZYRTEC ALLERGY
Tradename Dosage Ingredient NDA Submissiondate
CHILDREN'S ZYRTEC ALLERGY TABLET, CHEWABLE;ORAL cetirizine hydrochloride 021621 2005-03-25
CHILDREN'S ZYRTEC HIVES RELIEF TABLET, CHEWABLE;ORAL cetirizine hydrochloride 021621 2005-03-25

US Patents and Regulatory Information for CHILDREN'S ZYRTEC ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride SYRUP;ORAL 022155-002 Nov 16, 2007 OTC Yes Yes   Start Trial   Start Trial   Start Trial
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-003 Nov 16, 2007 DISCN Yes No   Start Trial   Start Trial   Start Trial
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-004 Nov 16, 2007 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CHILDREN'S ZYRTEC ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-003 Nov 16, 2007   Start Trial   Start Trial
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-004 Nov 16, 2007   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for CHILDREN'S ZYRTEC ALLERGY

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0058146 2001C/045 Belgium   Start Trial PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
0058146 SPC/GB01/052 United Kingdom   Start Trial SPC/GB01/052:, EXPIRES: 20070205
0663828 C300085 Netherlands   Start Trial PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Colorcon
Harvard Business School
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.